Myst Therapeutics - Ownership and Business Overview

Life ScienceCompany

Myst Therapeutics Ownership

Who owns Myst Therapeutics?

Myst Therapeutics is owned by Turnstone Biologics. It was acquired on January 20, 2021.

Myst Therapeutics Business Overview

Where is Myst Therapeutics headquartered?

Myst Therapeutics is headquartered in Los Angeles, California.

What sector is Myst Therapeutics in?

Myst Therapeutics is a life science company.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.

Myst Therapeutics, Inc.

570 Westwood Plaza Building 114,
Los Angeles, California 90095
United States,
www.myst-tx.com

Myst Therapeutics, Inc. is a biotechnology company focused on advancing novel T-cell therapies for solid tumors. Myst Therapeutics is pursuing the development of an adoptive cell therapy utilizing enriched T cells from tumors and peripheral blood that target a broad spectrum of cancer mutations. Myst Therapeutics is based in Los Angeles, California.


 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.